Quantitative Structure Activity Relationship Studies of Piperazinyl Phenylalanine Derivatives as VLA-4/VCAM-1 Inhibitors

被引:3
作者
Bhargava, Dinesh [1 ]
Karthikeyan, C. [1 ]
Moorthy, N. S. H. N. [1 ]
Trivedi, Piyush [1 ]
机构
[1] Rajiv Gandhi Proudyogiki Vishwavidyalaya, Sch Pharmaceut Sci, Bhopal 462036, Madhya Pradesh, India
关键词
QSAR; Piperazinyl phenylalanine; V-life; VLA-4/VCAM-1; MONOCLONAL-ANTIBODY; INTEGRIN;
D O I
10.2174/157340609789117822
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
QSAR study was carried out for a series of piperazinyl phenylalanine derivatives exhibiting VLA-4/VCAM-1 inhibitory activity to find out the structural features responsible for the biological activity. The QSAR study was carried out on V-life Molecular Design Suite software and the derived best QSAR model by partial least square (forward) regression method showed 85.67% variation in biological activity. The statistically significant model with high correlation coefficient (r(2) = 0.85) was selected for further study and the resulted validation parameters of the model, cross validated correlation coefficient (q(2) = 0.76 and pred_r(2) = 0.42) show the model has good predictive ability. The model showed that the parameters SaaNEindex, SsClcount SlogP, and 4PathCount are highly correlated with VLA-4/VCAM-1 inhibitory activity of piperazinyl phenylalanine derivatives. The result of the study suggests that the chlorine atoms in the molecule and fourth order fragmentation patterns in the molecular skeleton favour VLA-4/VCAM-1 inhibition shown by the title compounds whereas lipophilicity and nitrogen bonded to aromatic bond are not conducive for VLA-4/VCAM-1 inhibitory activity.
引用
收藏
页码:446 / 454
页数:9
相关论文
共 11 条
  • [1] A small-molecule, tight-binding inhibitor of the integrin α4β1 blocks antigen-induced airway responses and inflammation in experimental asthma in sheep
    Abraham, WM
    Gill, A
    Ahmed, A
    Sielczak, MW
    Lauredo, IT
    Botinnikova, Y
    Lin, KC
    Pepinsky, B
    Leone, DR
    Lobb, RR
    Adams, SP
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2000, 162 (02) : 603 - 611
  • [2] GEORGE AD, 2002, BIOORG MED CHEM LETT, V12, P729
  • [3] Anti-very late antigen-1 monoclonal antibody modulates the development of secondary lesion and T-cell response in experimental arthritis
    Ianaro, A
    Cicala, C
    Calignano, A
    Koteliansky, V
    Gotwals, P
    Bucci, M
    Gerli, R
    Santucci, L
    Fiorucci, S
    Cirino, G
    [J]. LABORATORY INVESTIGATION, 2000, 80 (01) : 73 - 80
  • [4] Evidence for a prolonged role of alpha(4) integrin throughout active experimental allergic encephalomyelitis
    Keszthelyi, E
    Karlik, S
    Hyduk, S
    Rice, GPA
    Gordon, G
    Yednock, T
    Horner, H
    [J]. NEUROLOGY, 1996, 47 (04) : 1053 - 1059
  • [5] MARIEAGNE S, 2007, MED CHEM LETT, V17, P142
  • [6] MILLER B, 2008, OPENSTAT SOFTWARE VE
  • [7] A controlled trial of natalizumab for relapsing multiple sclerosis.
    Miller, DH
    Khan, OA
    Sheremata, WA
    Blumhardt, LD
    Rice, GPA
    Libonati, MA
    Willmer-Hulme, AJ
    Dalton, CM
    Miszkiel, KA
    O'Connor, PW
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (01) : 15 - 23
  • [8] OSAMU S, 2008, BIOORG MED CHEM LETT, V18, P1053
  • [9] ATTENUATION OF COLITIS IN THE COTTON-TOP TAMARIN BY ANTI-ALPHA-4 INTEGRIN MONOCLONAL-ANTIBODY
    PODOLSKY, DK
    LOBB, R
    KING, N
    BENJAMIN, CD
    PEPINSKY, B
    SEHGAL, P
    DEBEAUMONT, M
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (01) : 372 - 380
  • [10] ANTIBODY TO VERY LATE ACTIVATION ANTIGEN-4 PREVENTS ANTIGEN-INDUCED BRONCHIAL HYPERREACTIVITY AND CELLULAR INFILTRATION IN THE GUINEA-PIG AIRWAYS
    PRETOLANI, M
    RUFFIE, C
    SILVA, JRLE
    JOSEPH, D
    LOBB, RR
    VARGAFTIG, BB
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (03) : 795 - 805